Article info

Download PDFPDF

Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case–control study in Asia

Authors

  • Tsai-Ling Liao Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Yi-Ming Chen Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taipei, Taiwan Faculty of Medicine, National Yang Ming University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Hung-Jen Liu Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Der-Yuan Chen Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taipei, Taiwan Faculty of Medicine, National Yang Ming University, Taipei, Taiwan Department of Medical Education, Taichung Veterans General Hospital, Taichung, Taiwan Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Der-Yuan Chen; dychen{at}vghtc.gov.tw
View Full Text

Citation

Liao T, Chen Y, Liu H, et al
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case–control study in Asia

Publication history

  • Received August 25, 2016
  • Revised November 10, 2016
  • Accepted November 30, 2016
  • First published January 5, 2017.
Online issue publication 
November 28, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.